axoCells Human iPSC-Derived Sensory Neurons (newborn male donor)
Specifications | |
---|---|
Product Category: | iPSC-Derived Cells |
Research Area: | Pain & Sensation |
Culture Properties: | Adherent |
Donor Age: | Newborn |
Donor Gender: | Male |
Reprogramming Method: | Episomal vector |
Product Description
axoCells Human iPSC-Derived Sensory Neurons for pain and sensation research. Sensory neurons made from iPSCs which were generated from a newborn male donor's cord blood.
- Assay-ready in just 21 days with our Maturation Maximizer media supplement
- Designed for advanced in vitro model formats including co-culture, microfluidics devices and organ-on-chip platforms
- Manufactured in our ISO 9001-accredited production facility with excellent ISSCR Standards compliance
Axol Human iPSC-Sensory Neuron Progenitors are derived from integration-free iPSCs and have been differentiated to neurons using small molecules. We offer a fully optimized cell culture system including tailored Sensory Maintenance Medium and coating reagents to promote the viability and maturation of sensory neurons for endpoint assays on glass or plastic.
Axol iPSC-derived sensory neurons express several voltage-gated sodium ion channels and transient receptor potential (TRP) ion channels that play a key role in nociception. These include sodium ion channels Nav1.7 and the DRG-specific, TTX-resistant channels, Nav1.8 and Nav1.9 as well as the temperature-sensitive, TRPV1 and TRPM8, and TRPA1, a sensor of pungency, bitterness and cold. iPSC-derived sensory neurons have functional relevance across multiple assays including capsaicin and menthol treatment, thermoception and neurite outgrowth with paclitaxel for a model of chemotherapy-induced peripheral neuropathy
Axol iPSC-Derived Sensory Neuron Progenitors are available in large batch sizes for reliable and consistent results in high-throughput screening assays. The cells are also suitable for investigating disorders of the peripheral nervous system and chronic pain as well as drug targets for pain relief.
Limited License Terms
Axol Bioscience's Limited License TermsGenetically Modified Organism (GVO)
See General Terms.
Product Citations
- Nishijima T, Okuyama K, Shibata S, Kimura H, Shinozaki M, Ouchi T, Mabuchi Y, Ohno T, Nakayama J, Hayatsu M, Uchiyama K, Shindo T, Niiyama E, Toita S, Kawada J, Iwamoto T, Nakamura M, Okano H, Nagoshi N. (2024) Novel artificial nerve transplantation of human iPSC-derived neurite bundles enhanced nerve regeneration after peripheral nerve injury Inflammation and Regeneration
- Xiaobo Han, Naoki Matsuda, Makoto Yamanaka, Ikuro Suzuki (2024) Development of a novel microphysiological system for neurotoxicity prediction using human iPSC-derived neurons with morphological deep learning bioRxiv
- Chase R, de la Peña JB, Smith PR, Lawson J, Lou TF, Stanowick AD, Black BJ, Campbell ZT. (2022) Global analyses of mRNA expression in human sensory neurons reveal eIF5A as a conserved target for inflammatory pain. The FASEB Journal
- Odawara A, Shibata M, Ishibashi Y, Nagafuku N, Matsuda N, Suzuki I. (2022) In Vitro Pain Assay Using Human iPSC-Derived Sensory Neurons and Microelectrode Array Toxicological Sciences
- Smulders PSH, Ten Hoope W, Bernardino Morcillo C, Hermanides J, Hollmann MW, Weber NC. (2022) Use of a human induced pluripotent stem cell-derived dorsal root ganglion neurone model to study analgesics in vitro: proof of principle using lidocaine British Journal of Anaesthesia (BJA)
- Catalog Number
ax0055-GVO-AX - Supplier
Axol Bioscience - Size
- Shipping
Dry Ice